COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations, Inc. Reports Third Quarter 2018 Financial Results
13/11/2018
Year-Over-Year Revenues Increase 29% to Third Quarter Record of $5.4 Million; Gross Margins Expand to Record 48.3%; Operating Expenses Decrease by 19% to $6.8 Million DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Sol-Gel Technologies Reports Third Quarter 2018 Financial Results
13/11/2018
NESS ZIONA, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update
13/11/2018
- Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis Planned for Fourth Quarter of 2018 - - Conference Call Today at 5:00 p.m. ET / 2:00 p.m. PT – SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Guardant Health To Report Third Quarter Financial Results on November 19, 2018
13/11/2018
REDWOOD CITY, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter of 2018 after market close on Monday, November 19, 2018. [...]
OpGen Reports third quarter 2018 Financial Results and Provides Business Update
13/11/2018
Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three and nine months ended [...]
iCAD Reports Third Quarter 2018 Financial Results
13/11/2018
Company announces board and leadership changes Conference call today at 4:30 p.m. ET NASHUA, N.H., Nov. 13, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative [...]
Imprimis Pharmaceuticals Announces Third Quarter 2018 Results
13/11/2018
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018. Third Quarter 2018 and Other Recent Notable Highlights: Revenues increased 66 [...]
Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first- [...]
CareDx Announces Proposed Public Offering of Common Stock
13/11/2018
BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
IntelGenx Closes Private Placement Financing
13/11/2018
SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic investment in IntelGenx by [...]
Synergy CHC Corp. Announces Third Quarter 2018 Results
13/11/2018
Westbrook, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the quarter ended September 30th [...]
Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Announcement of the filing of the Joint Terms of Merger
13/11/2018
Press release REGULATED INFORMATION Merger between Eckert & Ziegler BEBIG SA (BEBIG) and Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG ) - Announcement of the filing of the common draft terms of the [...]
Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Annonce du dépôt du projet commun de fusion transfrontalière (Projet Commun de Fusion)
13/11/2018
Communiqué de presse Information reglementée Fusion entre Eckert & Ziegler BEBIG SA (BEBIG) et Eckert & Ziegler Strahlen - und Medizintechnik AG (EZAG) - Annonce du dépôt du projet commun de fusion [...]
Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer
13/11/2018
Press release Malmö, November 13, 2018 Acarix (FN STO: ACARIX) today announced that the board of directors has appointed Per Persson to Chief Executive Officer. Per Persson comes directly from the role as Chief [...]
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
13/11/2018
COPENHAGEN, Denmark, November 13, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the share buy-back program, which was announced and initiated on November 9, 2018, has now been terminated, as the [...]
Dermatologists Urge Consumers to Treat Acne Early; American Academy of Dermatology
13/11/2018
Treating acne when it first appears can reduce severity, scarring and acne-related anxiety ROSEMONT, Ill., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Acne is the most common skin condition in the United States, affecting up to [...]
Cocrystal Pharma Announces Presentation of Preclinical Characterization Data of CC-42344 at the 6th ISIRV-AVG Conference
13/11/2018
- Company’s novel, broad spectrum influenza antivirals specifically designed to be effective against all significant A strains of the influenza virus - - CC-43244, Company’s lead molecule has demonstrated excellent [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
13/11/2018
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Søren Daniel Niegel 2. Reason for the [...]

Pages